Cleveland Clinic US

Minovia has entered into an agreement with the Cleveland Clinic to be the U.S. clinical trial site for the Phase I/II study of Mitochondrial Augmentation Therapy (MAT) in Pearson syndrome. This research will be conducted under the auspices of the Cleveland Clinic Children’s and the Mitochondrial Medicine Center within the Neurological Institute.